Introduction
The AGA Council section "Cellular and Molecular Gastroenterology" (CMG) has broad interests in the basic mechanisms underlying digestive diseases and gastrointestinal physiology. The recent name change from our past name, "Regulatory Peptides, Cell Signaling, and Molecular Biology," reflects the broad basic science focus of our section. From its origins in the study of gastrointestinal hormones, the section's membership has interests representing many areas of cutting-edge science, including growth factors and stem cells, cellular differentiation in the gastrointestinal (GI) tract, epigenetics, mechanisms of receptor function, basic physiology and cell biology, luminal chemosensing, intestinal inflammation, and mucosal injury and healing. CMG strives to invite outside speakers who are leading scientists in their fields to present forward-looking scientific programming at DDW.
We have an exciting line-up for DDW 2016. CMG will sponsor a distinguished abstract plenary session, 4 research symposia, 7 research fora, and 7 poster sessions. We had 189 abstracts submitted to our section, a marked increase over past years. We look forward to seeing you at DDW!
The GI Oncology section focuses on themes in oncology that pertain to multiple cancer types and is not restricted to a single organ site. Our membership is diverse, with basic scientists engaged in the investigation of fundamental mechanisms of cancer as well as organ-based cancer research; translational scientists involved in the application of basic findings to the clinical management of people at risk for cancer, people with premalignant lesions, or people with GI cancer; outcomes and epidemiology researchers, and clinical scientists interested in cancer prevention, screening, and new imaging technologies. We have more than 2000 members in our section, with recent growth seen in our international members, particularly in young international members.
Research Fora
The GI Oncology section has exciting research fora encompassing clinical, translational, and basic science. Our "Must See" research sessions for DDW 2016 are highlighted.
Saturday, May 21, 2016: "Barrett's Esophagus: New Models, New Signaling Pathways, and the Value of Acid Suppression." This translational research forum covers novel models to study Barrett's esophagus, new insights into molecular factors regulating the behavior of Barrett's esophagus, and the pros and cons of acid suppression for this condition. For anyone with an interest in Barrett's esophagus a "do not miss" summary talk putting these new findings into the current context of our knowledge of Barrett's esophagus will be delivered by Dr Stuart Spechler, an international expert in esophageal diseases, especially Barrett's esophagus.
Sunday, May 22, 2016: "Inflammation-Associated Gastric and Colon Carcinogenesis." This basic science research forum includes a set of exciting studies that advance our understanding of basic mechanisms involved in inflammation-associated cancer. The topics cover the role of inflammatory signaling in immune cell activation and novel roles of inflammatory factors in cancer biology. In addition, the impact of targeting "inflammation-activated receptors" as a potential therapeutic target will be presented. This session will occur on Sunday in the new Basic Science Themed Track entitled "Inflammation and GI Cancers."
Tuesday, May 24, 2016: "Endoscopic and Molecular Colon Cancer Screening and Surveillance: Benefits and Latest Advances." This translational research forum covers the pros and cons of currently available colon cancer screening tests including endoscopy, fecal occult blood testing/FIT, and molecular marker assays (eg, Cologuard), and will provide information on the latest advances in molecular strategies applicable to both screening and surveillance of colon cancer.
Distinguished Abstract Plenary
Monday, May 23, 2016: This session features some of the most highly rated abstracts submitted to DDW 2016 and will present the latest advances in the area of GI Oncology clinical and basic science research. Topics will cover advances in our understanding of the risk of colorectal cancer after a negative colonoscopy, and of the role of diet, microRNAs, and bacteria on colorectal cancer development. Other topics will include the role of gene fusions in esophageal adenocarcinoma and circulating neuroendocrine gene transcripts that predict the progression and recurrence of these tumors after surgery.
Symposia
Sunday, May 22, 2016: "GRG SPRING SYMPOSIUM: Inflammation in Cancer: Friend or Foe?" This cutting edge translational symposium will host a panel of international experts discussing inflammation as a "double-edge sword" in cancer. Dr Michael Karin will present "Inflammatory Pathways and Cancer Development" and Dr Michael Morse will present "Cancer Vaccines Making a Comeback." This is a "must see" session for investigators interested in both inflammation and cancer.
Monday "Overview and Implications for Understanding Gastric Diseases" by Dr Richard M. Peek. Dr Peek has led the field of gastric cancer research and his talk will conclude the session entitled, "Gastric Neoplasms: Precursors, Biology, Diagnosis, and Therapy."
Introduction
The Growth, Development, and Child Health (GDCH) section is the home for pediatrics and developmental biology within the AGA. The membership of the GDCH has the most diverse range of digestive health interests within the AGA, representing the interests of pediatrics within all digestive organ systems as well as basic science related to growth, development, and pediatrics.
Research Fora
The GDCH section will feature 7 fora at DDW 2016, the majority of which will showcase both abstract and invited presentations. 
Poster Sessions
The GDCH section planned 6 poster sessions. The topics include the following: "Pediatric IBD: Clinical and Translational Studies," "Pediatric Gut Microbiome and Microbiology," "Molecular Mechanisms of Growth, Differentiation, and Disease," "Clinical Pediatric Gastroenterology,"
Introduction
The Immunology, Microbiology, and Inflammatory Bowel Diseases (IMIBD) section covers important major scientific topics such as innate and adaptive immunity, genetics and the microbiome, animal models of IBD, mucosal immunology, epithelial cell biology, and stem cells.
Research Fora The poster hall will feature more than 600 posters submitted to the IMIBD section. Topics include the following: "IBD: Adverse Events Related to Therapy," "IBD: Comparative Effectiveness Studies," "IBD: Controlled Clinical Trials in Humans," "IBD: Diagnostics in IBD," "IBD: Disease Activity Assessment," "IBD: Disease Complications," "IBD: Epidemiology," "IBD: Natural History and Outcomes," "IBD: Practice Management/Quality of Care/Quality Assurance," "IBD: Quality of Life/Psychosocial Care," "IBD: 
The Intestinal Disorders (ID) section represents a community of clinical, translational, and basic scientists interested in disease-focused and pathway-driven processes underlying celiac disease; radiation-and chemotherapyinduced injury; diarrhea and malabsorption; microbial pathogenesis and mechanisms of microbe host cross-talk; nutrient, salt, and water transport; epithelial barrier function and wound repair; and epithelial functions in innate immunity. We aim to foster collaborations among interactive scientific communities by featuring outstanding basic, translational, and clinical research in these areas. These core values and goals are reflected in our programing at DDW.
Research Fora
For DDW 2016, the ID section is sponsoring and cosponsoring the following research fora:
Saturday Sunday, May 22, 2016: "Novel and Alternative Therapies for Celiac Disease" will include "Rationale for Alternative Therapies" (Peter H. Green), "Targets for Treatment" (Elena F. Verdu), "Current Status of Studies" (Joseph A. Murray), and "Evaluation and Management of Refractory Celiac Disease" (Ciaran P. Kelly).
Tuesday, May 24, 2016: "Updates on Acquisition and Therapy of Clostridium difficile" will include "Risk Factors and Preventive Practice in 2016" (Erik R. Dubberke), "The Benefits and Risks of FMT for C diff" (Colleen R. Kelly), and "Alternative Therapies for C diff: IVIG, Fidaxomicin, and Beyond" (Krishna Rao). 
State of the Art

Introduction
The membership of the Liver and Biliary (LB) section has remained balanced over the past 2 years; as of January 2015, more than 4900 active members are affiliated with the section, making it one of the largest sections. Domestic members comprise 67% of the section and international members comprise 23%. More than 18% of the members are trainees or young GIs. Other membership categories include senior members, residents, and nurse practitioners/ physician assistants.
Although the section is not the current leader in liverbiliary programming at DDW, we have made concerted efforts to work with the American Association for the Study of Liver Diseases to create joint programming for the benefit of our attendees.
Research Fora
The LB section is sponsoring 3 research fora, which will have oral abstract presentations centered on general themes. These include the following:
Saturday The clinical symposium on Saturday, May 21, 2016, is focused on "Controversies in Autoimmune Liver Disease." A panel of speakers will discuss topics including "Refractory AIH (Michael Heneghan), "Overlap Syndromes with PBC/PSC [Primary Biliary Cirrhosis/Primary Sclerosing Cholangitis] (Marilyn Mayo), and "Recurrent Disease After LT" (Aldo Montano-Loza). Autoimmune liver disease remains a challenging diagnostic and management problem for clinicians. This symposium will highlight those challenges and best approaches for management of these complex patients.
The clinical symposium on Sunday, May 22, 2016, will highlight the "Recent Advances in Acute on Chronic Liver Failure (ACLF)." Topics include the following: "Definition and Types of ACLF" (Jacqueline O'Leary), "Role of Infection in ACLF" (Jasmohan Bajaj), and "Role of Surgery in ACLF" (Patrick Kamath). Acute-on-Chronic Liver Failure frequently is unrecognized. This symposium will highlight the clinical issues in assessment and management of this difficult entity.
The AGA Emmet B. Keeffe Symposium on Sunday, May 22, 2016, will tackle the topic of "Assessing Hepatic Fibrosis-Truth, Lies and Wishes." Topics include the following: "Liver Biopsy and Computer Based Histomorphometry" (Zachary Goodman), "Laboratory Tests that Predict Fibrosis Stage" (Richard Sterling), and "Elastography-Shake Your Liver" (Nezam Afdhal). A worldclass group of speakers will honor the memory of Dr Emmet Keeffe by bringing clarity to the world of hepatic fibrosis determination.
Research Symposia
Two research symposia hybrid sessions will incorporate oral abstract presentations with invited talks.
The research symposium hybrid on Monday, May 23, 2016, is focused on "Hepatitis Prevention." The session will begin with the talk, "Treatment as Prevention-Breaking the HCV [Hepatitis C Virus] Epidemic" (Carmilla Graham), followed by this will be 2 abstract presentations and a period for questions and answers. A growing hepatitis C virus epidemic is spreading across the United States. This symposium will examine ways to prevent hepatitis C and other viral hepatitis infections.
Another research symposium hybrid on Monday, May 23, 2016, is focused on "Natural History of Viral Hepatitis," which will start off with "Hepatitis B-Stages, Transitions and Outcomes" (Anna Lok), afterward, 3 abstract presentations will follow. Hepatitis B disease staging remains a difficult problem for clinicians. This symposium will highlight new advances in our understanding of the natural history of hepatitis B virus and other hepatitis viruses.
Translational Symposia 
Poster Sessions
For DDW 2016, the LB section will offer multiple poster presentation forums for accepted scientific abstracts. The poster sessions will be divided into the following categories: 
Introduction
The Neurogastroenterology and Motility (NGM) section is pleased to present some outstanding advances in basic, translational, and clinical research at our San Diego meeting. There have been significant new developments in basic science and mechanisms, novel therapeutic targets, several refinements of diagnostic techniques, and several promising new drugs in the pipeline. At this DDW, the NGM section offerings reflect the broad spectrum of scientific discovery, innovation, and excitement, supplemented by a significant increase in abstract submissions. The NGM section received 503 abstracts and 396 were accepted, of which 84 will be presented orally and the rest as posters.
Research Fora
There are several ground-breaking and novel research fora in which cutting-edge science will be discussed. These include joint sessions co-sponsored by other sections. We introduce a novel feature of state-of-the-art lectures at the end of each oral abstract session to summarize and bring together the latest advances by an international expert in the field.
Saturday, May 21, 2016: "Novel Diagnosis and Treatments for Functional Dyspepsia, Bloating and GERD," "Advances in Cellular and Molecular Enteric Neurobiology," concluding with a state-of-the-art lecture entitled, "Novel Animal Models for Enteric Neurobiology" by Dr Pankaj J. Pasricha; "Emerging Paradigms in Enteric Sensory Neurobiology," concluding with a state-of-the-art lecture entitled, "Novel Targets for Treatment of Visceral Pain" by Dr Stuart Brierley; and a novel session entitled "Advances in Enteric Channels, Exchangers, and Transporters," which will conclude with a state-of-the-art lecture entitled, "Recent Advances in Our Understanding of Endocannabinoids and the Enteric Nervous System."
Sunday, May 22, 2016: "Microbiota, FODMAP Diet, and IBS" will include a state-of-the-art lecture by Dr William D. Chey on "FODMAP and IBS." "Clinical Advances in Swallowing Disorders," will conclude with a state-of-the-art lecture entitled, "Esophagogastric Junction Morphology Assessment in Health and Disease and Implications for Management" by Dr Peter Kahrilas. Another outstanding session entitled, "Diagnosis and Advances in Understanding and Management of Irritable Bowel Syndrome," will conclude with a state-of-the-art lecture entitled, "Diagnostic Testing in IBS: Looking Through the Crystal Ball" by Dr Brennan Spiegel. Finally, "Gastric and Small Bowel Motility and Dysmotility," will conclude with a state-of-the-art lecture entitled, "Management of Chronic Unexplained Nausea," by Dr William Hasler.
Monday, May 23, 2016: "Brain and Gut-Are They Talking?" This session will include a state-of-the-art lecture by Dr Qasim Aziz on this topic.
Tuesday, May 24, 2016: "Anorectal Disorders: Bench to Bedside" will include a state-of-the-art lecture by Dr Adil Bharucha on "Newer Diagnostic Tests for Anorectal Disorders: How Useful?" Also, we have "Constipation and Colonic Motility: What's New?," which will conclude with a state-ofthe-art lecture entitled, "Opioid-Induced Constipation: Who, Why, and How to Manage" by Dr Ashok Tuteja. Another exciting session is entitled, "Gastroparesis: Bench to Bedside," and will conclude with a state-of-the-art lecture entitled, "Advances in Pathophysiology and Diagnosis of Gastroparesis" by Dr Henry Parkman. Finally, we will cosponsor a pediatric forum entitled, "From Neonates to Adults: Keeping the Gut Moving."
Distinguished Abstract Plenary
On Monday, May 23, 2016, do not miss the best and most outstanding research in the field that will be presented at this NGM distinguished plenary session. Attendees will be able to listen and deliberate the most significant advances from bench to translational to clinical neurogastroenterology and motility. In addition, they will see the presentation of the 2016 Research Mentor Award to Jackie D. Wood, PhD, AGAF, RFF.
Symposia
The NGM section is sponsoring several research, translational, and clinical symposia that feature expert invited speakers and hot topics in neurogastroenterology and motility.
Building on a very successful program last year, on Monday, May 23, 2016, we again will use a new format of active audience participation and discussion centered on controversies and questions in clinical motility. Drs Peter Kahrilas, William Chey, and Satish Rao will chair the session entitled, "Motility Matters: An Interactive Forum to Debate What Progress the Field Has Made." This symposium will use a debate format with a panel led by a moderator to discuss new diagnostic modalities in motility disorders, pathophysiological correlates of symptoms in patients with functional and motility disorders, and critically evaluate the efficacy of newer approaches to treatment of motility disorders.
Another excellent clinical symposium on Sunday, May 22, 2016, entitled "New Concepts in Esophageal Physiology: The Role of Esophageal Wall Mechanics in Symptom Generation" will explore the pathogenesis of symptoms, esophageal biomechanics, and flow dynamics and cellular and molecular mechanisms for esophageal pain, and will be chaired by Drs Benson Massey and Abraham Khan.
The research symposium on Saturday, May 21, 2016, will be "Glia, ICC [Interstitial Cells of Cajal], and Smooth Muscle: Emerging Concepts and Future Directions." This state-of-the-art symposium chaired by Drs James Galligan and Fievos Christofi will bring experts in the field to discuss their groundbreaking research on the role of glia in neuromuscular function in health and disease, the role of interstitial cells of Cajal, and what is new in smooth muscle, and inform us about new directions we need to take and where the next generation of discoveries will come from. This year's first translational symposium will be on Saturday, May 21, 2016, and will focus on "Bacterial Metabolites in Gastrointestinal Diseases." Chaired by Drs Purna Kashyap and Elena Verdu, this innovative session will feature a discussion on the role of metagenomics, SCFA, and bacterial metabolites in the pathogenesis of IBS, IBD, obesity, and colon cancer, and how D-lactic acidosis, brain fogginess, and bacterial overgrowth may be linked.
The second translational symposium also will be held on Saturday, May 21, 2016, and will be entitled, "The BrainGut Axis-Novel Onsights from Translational Research." This exciting symposium chaired by Drs John Wiley and Emeran Mayer will articulate what is new in our understanding of the brain and gut axis as it relates to functional brain imaging, discuss the importance of these imaging techniques in functional pain disorders, and, importantly, examine the significance of performing reverse translational studies and test potential therapeutic interventions.
Poster Sessions Introduction
In recent years, DDW programming by the Obesity, Metabolism, and Nutrition (OMN) section has emphasized subject areas that have appealed to a majority of meeting attendees, especially those affiliated not only with the OMN section, but also other sections with which we share common interests, as reflected by our strong participation in cross-sectional programming. A major emphasis on obesity and nutritional and metabolic disorders was solidified by a section name change in 2013 to "Obesity, Metabolism, and Nutrition," reflecting a research and clinical focus on this spectrum of major health problems. New programming has included fora and symposia highlighting related topics, including bariatric surgery and its impact on nutritional status, GI neuroendocrinology and metabolism, new and innovative endoscopic and other treatments of obesity and diabetes, fatty liver disease, GI regulation of energy balance, weight and metabolic function, microbiota and metabolic regulation, and nutrition and metabolism across the life cycle. Nutritional support in all of its forms used in the management of a variety of diseases, including obesity, intestinal failure, and inflammatory bowel disease, as well as nutrient absorption and metabolism, also have continued to be the focus of OMN programming. The OMN section also has endeavored to strike a balance between basic research to shed light on disease mechanisms, including preclinical studies to develop new therapies, and clinical and translational research to better describe disease phenotypes and test new therapeutic approaches. This year, with the approval by the Food and Drug Administration of new endoscopic bariatric devices, we are emphasizing the use and effectiveness of these approaches in several sessions.
Research Fora
For DDW 2016, the OMN section is sponsoring 6 research fora, each with a focused theme and encompassing basic and translational research. These include the following.
Saturday, May 21, 2016: "Obesity: Clinical and Epidemiological Studies." Studies will be presented on the pathophysiology and clinical features of human obesity and its complications, as well as mechanisms and effectiveness of therapeutic interventions.
"Obesity Treatment: New Endoscopic Approaches." Abstracts will be presented on the use of new endoscopic bariatric procedures in obesity therapy, as well as their effectiveness, complications, and limitations.
Sunday, May 22, 2016: "Regulation of Food Intake, Energy Expenditure, and Metabolic Function." Research presented will involve brain-gut signaling networks that regulate caloric intake, energy expenditure, and metabolic function and the perturbations that occur in disease states, including obesity and diabetes.
"Obesity: Non-Surgical Treatment Effectiveness and Cost." Abstracts will cover nonsurgical approaches to obesity, including bariatric devices and pharmacotherapy, and their effectiveness and economic impact.
Monday, May 23, 2016: "Obesity: Basic Studies." Basic research will be presented on the normal physiologic regulation of mechanisms contributing to body mass and metabolic state, as well as perturbations that occur in obesity and diabetes, and amelioration by bariatric surgery and other therapeutic approaches.
Tuesday, May 24, 2016: "Nutrient and Vitamin Absorption and Metabolism." Abstracts will cover new research on the basic and clinical aspects of nutrient and vitamin absorption in health and disease.
Symposia
In addition to these research fora, the OMN section will be sponsoring 4 themed symposia.
Saturday, May 21, 2016: "Intestinal Nutrient Transporters as Endocrine Targets." Presenters at this research symposium will discuss how endocrine/paracrine signaling influences nutrient transporters and how nutrient flux across the intestinal epithelium is important for normal physiology and for the development of pathologic states. Talks Tuesday, May 24, 2016: "Approach to Obesity in Children: Not Just Small Adults." This clinical symposium will cover metabolic abnormalities and morbidities associated with obesity in children and their relationship to nutrition, genetics, and inflammation in the setting of the metabolic syndrome, as well as describe the approach to treatment of pediatric obesity, including the roles of nutrition, lifestyle changes, pharmacotherapy, and bariatric surgery in a multidisciplinary setting. Presentations include "Impact of Genetics on Pathogenesis and Response to Treatment in Pediatric Obesity" (Joan Han), "Metabolic Syndrome in
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The Pancreatic Disorders (PAN) section of the AGA Council has 2909 members, which is a 20% increase compared with 2015. For DDW 2016, PAN received 273 abstracts, which represents an increase of 23% over 1 year and 36% over 2 years. Abstract programming includes 40 (15%) accepted for oral presentation and 180 (66%) accepted for poster presentation. Two abstracts were selected for presentation at the AGA Presidential and Clinical Plenary Session.
The PAN section members' interests span from clinical practice to clinical, translational, and basic science investigation. Popular clinical and translational themes include acute and chronic pancreatitis; pancreatic necrosis; autoimmune pancreatitis; pancreatic cystic neoplasms, IPMN, and neuroendocrine tumors; cancer; pancreatic endoscopy and imaging; and pancreatic cancer risk factors, biomarkers, and diagnosis.
Basic science and translational themes focus on basic regulatory mechanisms and pathways relevant to popular PAN clinical topics, including inflammation and injury, immunology and fibrosis, healing and regeneration, growth, and neoplasia. These basic interests are organized under 3 abstract descriptors, including: Pancreatic genetics, epigenetics, physiology, cell biology, and pathobiology; Pancreatitis: inflammation, fibrogenesis, and immunology; and Microbiome and pancreatic disease.
Research Fora Symposia
For DDW 2016 the PAN section is sponsoring or cosponsoring a Collaborative Global Topic Symposium, 3 translational symposia, and 4 clinical symposia.
The Collaborative Global Topic Symposium Saturday, May 21, 2016, focuses on "Regenerative Medicine: Emerging Therapy for Pancreatic and GI Tract Disorders" and will highlight the key concepts and tools of regenerative medicine and application to the pancreas and intestinal tract. Topics include the following: "Nuclear Reprogramming Factors: Mechanistic Players and Therapeutic Tools in
